Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial

New dengue vaccines are needed to prevent this globally expanding vector-borne disease. The V180 vaccine candidate consists of four recombinant, soluble, dengue virus envelope glycoproteins and has been previously evaluated in two clinical trials for safety and immunogenicity in Flavivirus-naive par...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Trop Med Hyg
Main Authors: Durbin, Anna P., Pierce, Kristen K., Kirkpatrick, Beth D., Grier, Palmtama, Sabundayo, Beulah P., He, Helen, Sausser, Michele, Russell, Amy Falk, Martin, Jason, Hyatt, Donna, Cook, Melissa, Sachs, Jeffrey R., Lee, Andrew Wen-Tseng, Wang, Liman, Coller, Beth-Ann, Whitehead, Stephen S.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Tropical Medicine and Hygiene 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410446/
https://ncbi.nlm.nih.gov/pubmed/32394880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.20-0042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados